ATE205199T1 - Quinolin- oder quinazolinderivate, deren herstellung und verwendung - Google Patents

Quinolin- oder quinazolinderivate, deren herstellung und verwendung

Info

Publication number
ATE205199T1
ATE205199T1 AT94101144T AT94101144T ATE205199T1 AT E205199 T1 ATE205199 T1 AT E205199T1 AT 94101144 T AT94101144 T AT 94101144T AT 94101144 T AT94101144 T AT 94101144T AT E205199 T1 ATE205199 T1 AT E205199T1
Authority
AT
Austria
Prior art keywords
quinoline
production
quinazoline derivatives
integer
nitrogen
Prior art date
Application number
AT94101144T
Other languages
English (en)
Inventor
Takashi Sohda
Haruhiko Makino
Atsuo Baba
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE205199T1 publication Critical patent/ATE205199T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
AT94101144T 1993-01-28 1994-01-27 Quinolin- oder quinazolinderivate, deren herstellung und verwendung ATE205199T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1262893 1993-01-28
JP20612893 1993-08-20

Publications (1)

Publication Number Publication Date
ATE205199T1 true ATE205199T1 (de) 2001-09-15

Family

ID=26348258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94101144T ATE205199T1 (de) 1993-01-28 1994-01-27 Quinolin- oder quinazolinderivate, deren herstellung und verwendung

Country Status (15)

Country Link
US (3) US5436247A (de)
EP (1) EP0608870B1 (de)
KR (1) KR100224135B1 (de)
CN (1) CN1041520C (de)
AT (1) ATE205199T1 (de)
AU (1) AU673213B2 (de)
CA (1) CA2114300C (de)
DE (1) DE69428142T2 (de)
FI (1) FI940414L (de)
HU (1) HU217907B (de)
NO (2) NO306992B1 (de)
NZ (1) NZ250761A (de)
RU (1) RU2132330C1 (de)
SG (1) SG50546A1 (de)
TW (1) TW256832B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW232013B (de) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
EP0634169B1 (de) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
WO1995024394A1 (en) * 1994-03-08 1995-09-14 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis
US5641788A (en) * 1994-06-07 1997-06-24 Takeda Chemical Industries, Ltd. Quinoline derivatives and pharmaceutical composition containing them
US5698699A (en) * 1994-06-24 1997-12-16 Takeda Chemical Industries, Ltd. Processes for production of quinoline or quinazoline derivatives and intermediates therefor
US5523312A (en) * 1994-09-27 1996-06-04 Sterling Winthrop Inc. Antipicornaviral agents
KR19990008148A (ko) * 1995-04-28 1999-01-25 다께다 구니오 관절염 치료 조성물
DE19610882A1 (de) * 1996-03-20 1997-09-25 Dresden Arzneimittel Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1001945B1 (de) * 1997-05-28 2011-03-02 Aventis Pharmaceuticals Inc. CHINOLIN UND CHINOXALINVERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMENDEN FAKTOR UND/ODER p56Ick-TYROSINKINASE HEMMEN
DE19728835C1 (de) * 1997-07-05 1998-09-10 Ruetgers Vft Ag Verfahren zur Reinigung von Chinaldin
KR100763779B1 (ko) * 2000-01-17 2007-10-05 데이진 가부시키가이샤 벤즈이미다졸 유도체
EP1354603A1 (de) * 2000-12-26 2003-10-22 Takeda Chemical Industries, Ltd. Begleitmedikamente
RU2183116C1 (ru) * 2001-07-10 2002-06-10 Жаров Олег Владимирович Фармацевтическая композиция, обладающая болеутоляющим, противовоспалительным, антипиретическим и спазмолитическим действием
JP4498923B2 (ja) * 2002-07-15 2010-07-07 サイノファーム タイワン リミテッド イミダゾ(1,2−a)ピリジン−3−アセトアミド類の調製方法
EP1568693A4 (de) * 2002-11-06 2007-09-05 Nissan Chemical Ind Ltd Verfahren zur herstellung von chinolincarbaldehyd
ES2290743T3 (es) * 2003-04-30 2008-02-16 The Institutes For Pharmaceutical Discovery, Llc Heteroarilos sustituidos como inhibidores de las proteina-tirosina fosfatasas.
US7937406B2 (en) * 2003-09-11 2011-05-03 Oracle America, Inc. Mechanism for automatically establishing a resource grid
AU2005300822B2 (en) * 2004-11-01 2010-12-02 F. Hoffmann-La Roche Ag Quinoline as allosteric enhancers of the GABA-B receptors
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US20070225632A1 (en) * 2006-03-21 2007-09-27 David Rauser Hydratable polymeric ester matrix for drug electrotransport
EA201270013A1 (ru) 2009-06-25 2012-06-29 Амген Инк. Гетероциклические соединения и их применение
MX2013005567A (es) 2010-11-17 2013-10-30 Amgen Inc Derivados de quinolina como inhibidores de pik3.
KR20150046056A (ko) * 2012-08-24 2015-04-29 에프. 호프만-라 로슈 아게 신규한 바이사이클릭피리딘 유도체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5084462A (en) * 1988-04-26 1992-01-28 The Du Pont Merck Pharmaceutical Company 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents
GB8827822D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
TW232013B (de) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
US5698699A (en) * 1994-06-24 1997-12-16 Takeda Chemical Industries, Ltd. Processes for production of quinoline or quinazoline derivatives and intermediates therefor

Also Published As

Publication number Publication date
TW256832B (de) 1995-09-11
KR100224135B1 (ko) 1999-10-15
AU5474294A (en) 1994-08-04
NO940245D0 (no) 1994-01-24
US5436247A (en) 1995-07-25
DE69428142D1 (de) 2001-10-11
CA2114300C (en) 2000-10-17
US5932592A (en) 1999-08-03
NO940245L (no) 1994-07-29
FI940414A7 (fi) 1994-07-29
US5770602A (en) 1998-06-23
KR940018381A (ko) 1994-08-16
SG50546A1 (en) 1998-07-20
FI940414A0 (fi) 1994-01-27
CA2114300A1 (en) 1994-07-29
CN1105363A (zh) 1995-07-19
CN1041520C (zh) 1999-01-06
RU2132330C1 (ru) 1999-06-27
HU217907B (hu) 2000-05-28
NO306992B1 (no) 2000-01-24
NZ250761A (en) 1995-03-28
FI940414L (fi) 1994-07-29
DE69428142T2 (de) 2002-07-04
HU9400250D0 (en) 1994-05-30
AU673213B2 (en) 1996-10-31
EP0608870B1 (de) 2001-09-05
HUT70194A (en) 1995-09-28
EP0608870A1 (de) 1994-08-03

Similar Documents

Publication Publication Date Title
ATE205199T1 (de) Quinolin- oder quinazolinderivate, deren herstellung und verwendung
NO953305D0 (no) Antranilsyrederivat
NO955023L (no) Piperidinderivater og fremgangsmåte for fremstilling derav
ATE124699T1 (de) Tricyclische carbapenemverbindungen.
FI933357A0 (fi) Foerfarande foer framstaellning av benzamider
FI924397A0 (fi) Substituerade pyrimidiner.
RU94002335A (ru) Производные хинолина или хиназолина и способ их получения
ZA93267B (en) Novel arylcyloakyl derivatives their production and their use
AU652981B2 (en) Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
ES2157214T3 (es) Procedimiento para producir derivados de azetidinona sustituidos en posicion 4.
NO931482D0 (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
DE3882895D1 (de) Imid-derivate, ihre herstellung und verwendung.
NO179746C (no) 1-aryloksy-3-alkylamino-2-propanolnitratestere, deres anvendelse og tilsvarende farmasöytiske blanding
EP0760362A4 (de) Neue diaminomethyliden-derivate
DE69429185D1 (de) Imidazolidinon-derivate, deren säure-additionssalze und mittel gegen senile demenz
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
PT90302A (pt) Processo para a preparacao de derivados de lactamas hetero-tetraciclicas
ATE179170T1 (de) 3-substituierte pyridinverbindungen und deren derivate als herbizide
ATE160339T1 (de) Benzimidazolderivate, verfahren zur herstellung, zwischenprodukte, und diese als aktive bestandteile enthaltende antiemetische substanzen
DE68903188D1 (de) Acylsulfonamid-derivate von alpha-carbocyclyltoluylsaeuren und ihre verwendung als leukotrienantagonisten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties